Review: rivastigmine may improve cognitive outcomes in Alzheimer's disease

Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life

Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by a progressive loss of cognitive and functional abilities associated with various behavioral disturbances. Its impact on public health and society as a whole is devastating. Slowing of the cognitive impairment, and improvements in disease duration, self-sufficiency and behavioral disturbances represent the best out...

treatment of gastro-esophageal reflux disease may improve surgical outcomes for chronic otitis media

background this study has been designed to investigate the clinical association between gastro esophageal reflux disease (gerd) and chronic otitis media (com) in adults and also the role of gerd treatment on the outcome of com surgery. methods in a randomized clinical trial, 58 patients with com who were candidates for surgery were evaluated for gerd and divided in two groups; gerd posi­tive (c...

Cognitive training may improve targeted cognitive functions in older adults.

Participants 2802 older adults recruited from senior housing, community centres, clinics and driver’s licence registries. Mean age 73.6 years (range 65–94); 76% women; 73% white. Exclusion criteria were age under 65 years; not living independently; recent cognitive training; substantial cognitive decline; Alzheimer’s disease; medical conditions with increased risk of functional decline or death...

Alzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins

Alzheimer's disease (AD) is the most common neurodegenerative disorder. Currently available therapies are symptomatic but do not alter underlying disease progression. Immunotherapeutic approaches such as anti Aβ peptide active vaccination trials have had limited success to date. Intravenous immunoblobulin (IVIg) is widely used in immune-mediated neurological disorders such myasthenia gravis and...

Cognitive Impairments in Siblings of Alzheimers Disease Patients: Possible Preclinical Signs of the Disease